MYGN
Myriad Genetics Inc
Price:  
14.51 
USD
Volume:  
964,913.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MYGN WACC - Weighted Average Cost of Capital

The WACC of Myriad Genetics Inc (MYGN) is 8.6%.

The Cost of Equity of Myriad Genetics Inc (MYGN) is 8.70%.
The Cost of Debt of Myriad Genetics Inc (MYGN) is 7.00%.

Range Selected
Cost of equity 7.00% - 10.40% 8.70%
Tax rate 16.50% - 20.80% 18.65%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.0% - 10.2% 8.6%
WACC

MYGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.69 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 10.40%
Tax rate 16.50% 20.80%
Debt/Equity ratio 0.03 0.03
Cost of debt 7.00% 7.00%
After-tax WACC 7.0% 10.2%
Selected WACC 8.6%